Back to top
more

Meridian Bioscience Inc. (VIVO)

(Delayed Data from NSDQ)

$11.51 USD

11.51
1,168,817

-0.48 (-4.00%)

Updated May 3, 2019 04:00 PM ET

After-Market: $11.50 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Abbott's (ABT) Q1 Earnings and Revenues Exceed Estimates

Within Adult Nutrition, Abbott (ABT) gains from the strong performance of Ensure and Glucerna brands in Q1.

Exact Sciences (EXAS) to Post Q1 Earnings: What's in Store?

Robust global demand for Oncotype DX and increased Cologuard orders are likely to have driven Exact Sciences' (EXAS) Q1 performance.

Edwards Lifesciences (EW) to Post Q1 Earnings: What's in Store?

Improvement in TAVR and TMTT businesses is expected to have contributed to Edwards Lifesciences' (EW) first-quarter performance.

What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?

Excluding COVID testing sales, Abbott's (ABT) worldwide Diagnostic sales are expected to have demonstrated strong growth in Q1 on the continuous rollout of Alinity, Abbott's suite of diagnostic instruments.

Quest Diagnostics (DGX) Q1 Earnings to Grow on Base Business

Quest Diagnostics (DGX) is expected to report a strong first half of Q1 with a growing number of cases and then a dull second half on gradual stabilization in testing demand.

Zacks.com featured highlights include Meridian Bioscience, Innoviva, OP Bancorp and United Fire Group

Meridian Bioscience, Innoviva, OP Bancorp and United Fire Group are part of Screen of the Week article.

What Makes Meridian Bioscience (VIVO) a Good Fit for "Trend Investing"

Meridian Bioscience (VIVO) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Nilanjan Banerjee headshot

Bet on These 4 Low-Beta Stocks to Combat Market Volatility

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), Innoviva (INVA), OP Bancorp (OPBK) and United Fire Group (UFCS) are well poised to gain.

New Strong Buy Stocks for March 25th

CLH, VIVO, EOG, TGT, and COLM have been added to the Zacks Rank #1 (Strong Buy) List on March 25, 2022.

Zacks.com featured highlights include Meridian Bioscience, OP Bancorp, ICU Medical and Pangaea Logistics Solutions

Meridian Bioscience, OP Bancorp, ICU Medical and Pangaea Logistics Solutions have been highlighted in this Screen of the Week article.

Nilanjan Banerjee headshot

Buy These 4 Low-Beta Stocks to Combat the Choppy Market

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), OP Bancorp (OPBK), ICU Medical (ICUI) and Pangaea Logistics (PANL) are well poised to gain.

New Strong Buy Stocks for March 22nd

AA, HLI, RUSHA, COLM, and VIVO have been added to the Zacks Rank #1 (Strong Buy) List on March 22, 2022.

Meridian Bioscience and NeuroPace have been highlighted as Zacks Bull and Bear of the Day

Meridian Bioscience and NeuroPace have been highlighted as Zacks Bull and Bear of the Day.

Kevin Cook headshot

Bull of the Day: Meridian Bioscience (VIVO)

Beat-and-raise quarter launches shares and estimates as growth in diagnostics returns

Zacks.com featured highlights include Meridian Bioscience, Innoviva, Horace Mann Educators and Maravai LifeSciences

Meridian Bioscience, Innoviva, Horace Mann Educators and Maravai LifeSciences are included in this blog.

Nilanjan Banerjee headshot

Sail Through the Choppy Market With These 4 Low-Beta Stocks

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), Innoviva (INVA), Horace (HMN) and Maravai LifeSciences (MRVI) are well poised to gain.

Will Meridian Bioscience (VIVO) Gain on Rising Earnings Estimates?

Meridian Bioscience (VIVO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Meridian Bioscience (VIVO) Q1 Earnings and Revenues Surpass Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 40% and 19.78%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Meridian Bioscience (VIVO) Q1 Earnings Expected to Decline

Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Meridian Bioscience (VIVO) Earnings Expected to Grow: Should You Buy?

Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Meridian Bioscience (VIVO) Q3 Earnings and Revenues Miss Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of -29.03% and -13.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks.com featured highlights include: Danaos Corp, Boyd Gaming, Costamare, Meridian Bioscience and Magnolia Oil & Gas

Zacks.com featured highlights include: Danaos Corp, Boyd Gaming, Costamare, Meridian Bioscience and Magnolia Oil & Gas

Nitish Marwah headshot

4 Profitable Stocks to Boost Returns Using Net Income Ratio

DAC, BYD, CMRE, VIVO, and MGY qualified the screen for the net income ratio for the day.

Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for

Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Meridian Bioscience (VIVO) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Meridian Bioscience (VIVO) closed at $22.05, marking a +1.61% move from the previous day.